Literature DB >> 24796616

Ten-gene biomarker panel: a new hope for ovarian cancer?

Dong-Joo Cheon1, Sandra Orsulic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24796616      PMCID： PMC4330556          DOI： 10.2217/bmm.14.16

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  20 in total

Review 1.  Tumors as organs: complex tissues that interface with the entire organism.

Authors:  Mikala Egeblad; Elizabeth S Nakasone; Zena Werb
Journal:  Dev Cell       Date:  2010-06-15       Impact factor: 12.270

2.  Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides.

Authors:  Miranda P Ween; Katja Hummitzsch; Raymond J Rodgers; Martin K Oehler; Carmela Ricciardelli
Journal:  Clin Exp Metastasis       Date:  2010-12-12       Impact factor: 5.150

Review 3.  Mouse models of cancer.

Authors:  Dong-Joo Cheon; Sandra Orsulic
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 4.  Dynamic interplay between the collagen scaffold and tumor evolution.

Authors:  Mikala Egeblad; Morten G Rasch; Valerie M Weaver
Journal:  Curr Opin Cell Biol       Date:  2010-09-06       Impact factor: 8.382

5.  Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1.

Authors:  Hoon Kim; John Watkinson; Vinay Varadan; Dimitris Anastassiou
Journal:  BMC Med Genomics       Date:  2010-11-03       Impact factor: 3.063

6.  A gene-expression signature as a predictor of survival in breast cancer.

Authors:  Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke Witteveen; Annuska Glas; Leonie Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

7.  A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.

Authors:  Tomas Bonome; Douglas A Levine; Joanna Shih; Mike Randonovich; Cindy A Pise-Masison; Faina Bogomolniy; Laurent Ozbun; John Brady; J Carl Barrett; Jeff Boyd; Michael J Birrer
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

8.  A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.

Authors:  Pierre Farmer; Hervé Bonnefoi; Pascale Anderle; David Cameron; Pratyaksha Wirapati; Pratyakasha Wirapati; Véronique Becette; Sylvie André; Martine Piccart; Mario Campone; Etienne Brain; Gaëtan Macgrogan; Thierry Petit; Jacek Jassem; Frédéric Bibeau; Emmanuel Blot; Jan Bogaerts; Michel Aguet; Jonas Bergh; Richard Iggo; Mauro Delorenzi
Journal:  Nat Med       Date:  2009-01-04       Impact factor: 53.440

9.  COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.

Authors:  Y-H Wu; T-H Chang; Y-F Huang; H-D Huang; C-Y Chou
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

10.  The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells.

Authors:  Alla Bondareva; Charlene M Downey; Fabio Ayres; Wei Liu; Steven K Boyd; Benedikt Hallgrimsson; Frank R Jirik
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240
View more
  3 in total

1.  Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.

Authors:  Christian Gerecke; Bettina Scholtka; Yvonne Löwenstein; Isabel Fait; Uwe Gottschalk; Dorothee Rogoll; Ralph Melcher; Burkhard Kleuser
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-23       Impact factor: 4.553

2.  Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.

Authors:  Miran Rada; Sameera Nallanthighal; Jennifer Cha; Kerry Ryan; Jessica Sage; Catherine Eldred; Maria Ullo; Sandra Orsulic; Dong-Joo Cheon
Journal:  Oncogene       Date:  2018-05-17       Impact factor: 9.867

3.  Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation.

Authors:  Zhenqiu Liu; Jessica A Beach; Hasmik Agadjanian; Dongyu Jia; Paul-Joseph Aspuria; Beth Y Karlan; Sandra Orsulic
Journal:  Gynecol Oncol       Date:  2015-09-06       Impact factor: 5.482
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.